Literature DB >> 2831045

Evaluation of three methods for typing herpes simplex virus.

F Salmerón1, P Pérez Breña, J M Rojas, R Hernáez Lobo, E Tabarés.   

Abstract

Three methods of typing herpes simplex virus were compared. A total of 111 clinical isolates obtained from patients not treated with antivirals and seven resistant mutants selected in vitro were tested by immunofluorescence assay using antibodies against herpes simplex virus types 1 and 2. Twenty-nine isolates were also studied by restriction endonuclease analysis. The sensitivity of isolates and resistant mutants to (E)-5-(2-bromovinyl)-2'-deoxyuridine was determined. Although a clear difference between the 50% inhibitory dose for type 1 and type 2 isolates was observed, some drug-resistant mutants might be misidentified by this method.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2831045     DOI： 10.1007/BF02013066

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


  10 in total

1.  Anatomy of herpes simplex virus DNA: strain differences and heterogeneity in the locations of restriction endonuclease cleavage sites.

Authors:  G S Hayward; N Frenkel; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

2.  Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.

Authors:  J M Reno; L F Lee; J A Boezi
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

3.  A new method for the isolation of herpes simplex virus type 2 DNA.

Authors:  J M Walboomers; J T Schegget
Journal:  Virology       Date:  1976-10-01       Impact factor: 3.616

4.  Problems associated with the use of (E)-5-(2-bromovinyl)-2'-deoxyuridine for typing herpes simplex virus.

Authors:  E M Swierkosz; M Q Arens; K A Rivetna
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

5.  A rapid technique for distinguishing herpes-simplex virus type 1 from type 2 by restriction-enzyme technology.

Authors:  D M Lonsdale
Journal:  Lancet       Date:  1979-04-21       Impact factor: 79.321

6.  A comparative analysis of restriction enzyme digests of the DNA of herpes simplex virus isolated from genital and facial lesions.

Authors:  S M Chaney; K G Warren; J Kettyls; A Zbitnue; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1983-02       Impact factor: 3.891

7.  Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.

Authors:  E De Clercq; J Descamps; G Verhelst; R T Walker; A S Jones; P F Torrence; D Shugar
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

8.  Differentiation of herpes simplex virus types 1 and 2 by sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.

Authors:  D R Mayo
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

9.  Monoclonal antibodies to herpes simplex viruses: use in antigenic typing and rapid diagnosis.

Authors:  L C Goldstein; L Corey; J K McDougall; E Tolentino; R C Nowinski
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

10.  Type-common and type-specific monoclonal antibody to herpes simplex virus type 1.

Authors:  L Pereira; T Klassen; J R Baringer
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.